News | Cath Lab | August 27, 2015

Improving Stent Designs With Computational Fluid Dynamics

Blood flow mapping confirms improved blood flow with new stent graft design

Stent graft, computational fluid dynamics, CFD, stent engineering

In this vector velocity model, brighter colors indicate blood flow acceleration as it passes through a bifurcation. Computation fluid dynamic modeling provides insight on blood flow through and near the walls of the stent graft. Image courtesy of Sanford Health

Stent graft

Sanford Health vascular surgeon Pat Kelly developed a stent graft that can be deployed from the top on down to help patient with thoracoabdominal aneurysms. Using fluid flow modeling, South Dakota State University mechanical engineering associate professor Stephen Gent confirmed that the cascading design improved blood flow behavior. Image courtesy of Sanford Health

August 27, 2015 — The use of computational fluid dynamics (CFD) modeling has been used for years to better engineer large machines such as aircraft and automobiles, but its application is now being turned toward implantable medical devices such as stents, stent grafts and heart valves. Last November, the U.S. Food and Drug Administration (FDA) approved the first medical technology that uses CFD to create noninvasive fraction flow reserve (FFR) measurements of blood flow through coronary lesions based on a computed tomography (CT) scan.

Software engineers are a few imaging device companies recently released vector flow imaging software for both magnetic resonance imaging (MRI) and ultrasound that can track the microscopic blood flow and vortices created within the heart or blood vessels. It is believed wall shear stress and vortices may negatively impact the function of the devices, or cause blood flow issues that lead to poorer outcomes later on.

Vascular surgeon Pat Kelly of Sanford Health in Sioux Falls, S.D, recently undertook an example of the new technology for blood flow analysis to help engineer new devices. He knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more widely in a clinical trial. For that, he reached out to South Dakota State University (SDSU) Associate Professor Stephen Gent. He has been involved in mechanical engineering to perform computational fluid dynamics modeling for more than 10 years, but this was his first experience simulating blood flow.

Their research partnership has been a successful one. The Sanford Health team began a FDA clinical trial on the device in March with the support of data from the computational fluid dynamics simulation and the patients Kelly has treated. In April, Sanford Health signed a licensing deal with Medtronic that will bring this life-saving device closer to commercialization. The research was supported by a grant from Sanford Frontiers.

Setting Up The Model
“This is not a trivial problem,” Gent said, noting that blood is a pulsed flow. He and graduate student Taylor Suess used a commercially available computational fluid dynamics solver, Star CCM+, and wrote additional code to model blood flow through five stents. Three were commercially available, while two, including Kelly’s, were new designs. First, the researchers had to learn the medical terminology and then link the engineering results with what mattered to the medical professionals. “The language overlapped about 60 percent,” Gent said, “but it helped that Kelly was a structural engineer before becoming a surgeon.”

To compare the devices, Suess had to create a geometrically correct model of each graft relative to the same aorta coordinates and positioning in the body trunk and the arteries that feed the organs and extend into the legs. “I spent a significant time modifying the computer aided drawing (CAD) files to make the comparison as fair as possible,” he pointed out.

Simulating Blood Flow
Simplified blood flow resembles a liquid moving through pipes from a fluids analysis perspective, but Suess pointed out, “the boundary conditions are intricate and the parameters aren’t well-known.”

To capture what was happening to blood flow near the artery walls where atherosclerosis tends to begin, the researchers had to write their own code. They had to consider oscillating shear index, time-averaged wall shear stress, relative residence time and wall shear stress temporal gradient. “The longer the blood stays at one site, the greater the chance white blood cells will build up and cause thickening of the artery walls,” Suess said. That narrowing then increases the shear stress on the vessel wall.

Sanford Health biomedical engineer Tyler Remund, who is part of Kelly’s product development team, explained the arteries that feed the kidneys are very prone to clotting. Remund earned his bachelor’s in mechanical engineering from SDSU and then completed his doctorate in biomedical engineering at the University of South Dakota.

“The challenge that has faced the industry is keeping the renal vessels open,” he added, noting that the short length and small diameter of renal arteries leave them prone to narrowing once stented. To account for the transient pulsatile flow of blood, Suess imported an extensive data table into the software that specifies the volumetric flow rate of the blood through the system every 5,000th of a second and outputs a solution every 1,000th of a second to make a simulation for a one-second cycle.

Traditionally, blood flow is modeled as a non-Newtonian fluid; however, the researchers found that these properties apply to arterioles and capillaries that are 1 millimeter or less in diameter. When Suess compared simulations using Newtonian and non-Newtonian fluid properties, he found “almost no difference.”

Opening Up Opportunities
The fluid flow modeling “helped validate that the configuration is delivering more well developed blood flow with the design,” according to Kelly.

“The simulation shows flow behavior next to the artery wall is more ordered, predictable and moderate with the design. It splits the blood flow upstream and lets it gradually come to the renals,” he said. Gent and Suess confirmed this when they ran the computer simulations.

Only a small number of patients — two per 100,000 a year — are diagnosed with thoracoabdominal aneurysms, according to Kelly. However, most of these patients would not survive traditional surgery, which involves an incision from the chest to the groin.

“This less invasive approach could give more patients an option,” Kelly pointed out.

This project could lead to more opportunities for the engineering researchers. Gent accompanied the Sanford surgeon to a conference where Kelly presented the work they had done.

“We have a lot of options moving forward,” Suess said. “We can do this type of modeling for any stent.”

For more information: www.sanfordhealth.org

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init